> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CTTI Releases Mobile Tech Tools, Recommendations
- URL: https://www.fdaweb.com/ctti-releases-mobile-tech-tools-recommendations/
- Published: 2017-06-28T12:00:00.000Z
- Updated: 2026-09-14T22:32:07.000Z
- Author: David McFarland
- Tags: Drugs, Devices, #legacy-id-D5139049

The Clinical Trials Transformation Initiative (CTTI) has released recommendations and tools to provide a pathway for using information gathered from mobile technologies to accelerate development and evaluation of new therapies. The recommendations and tools are designed to help diverse stakeholders identify and develop novel endpoints based on data from mobile technologies for use in regulatory clinical trials, CTTI [says](https://www.ctti-clinicaltrials.org/news/ctti-seeks-speed-use-mobile-technology-clinical-trials-through-novel-endpoint-recommendations?ref=fdaweb.com) (contains link to recommendations and tools).

“Technology-derived endpoints offer the benefit of capturing information about patients’ experience in ‘real-world’ settings,” says CDER director **Janet Woodcock**. “These tools have the potential to capture data that can be used to develop endpoints and evaluate therapies in the patient population.”

CTTI says its “novel endpoints” recommendations are the first to be released as part of a larger body of work to address multiple challenges to using mobile technology in clinical trials. The institute’s Mobile Clinical Trials Program includes additional projects on legal and regulatory considerations, stakeholder perceptions, and scientific and technical issues related to using mobile devices. Recommendations from those projects will be issued over the next year, CTTI says.